Castle Biosciences Inc. (CSTL)

NASDAQ: CSTL · Real-Time Price · USD

19.31

-0.74 (-3.69%)

At close: May 01, 2025, 3:59 PM

19.34

0.16%

Pre-market: May 02, 2025, 04:10 AM EDT

Castle Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	332.07M	219.79M	137.04M	94.08M	62.65M	51.87M	22.79M	13.75M
Cost of Revenue	60.2M	44.98M	32.01M	15.82M	9.69M	7.31M	5.3M	4.92M
Gross Profit	271.86M	174.81M	105.03M	78.26M	52.96M	44.55M	17.49M	8.83M
Operating Income	8.67M	-67.98M	-91.14M	-40.08M	-6.54M	4.71M	-3.84M	-10.9M
Interest Income	12.92M	10.62M	3.97M	68K	373K	312K	23.51K	26.18K
Pretax Income	21.56M	-57.37M	-68.9M	-40.01M	-10.2M	5.35M	-6.36M	-12.36M
Net Income	18.25M	-57.47M	-67.14M	-31.29M	-10.28M	5.28M	-6.37M	-12.37M
Selling & General & Admin	200.05M	180.15M	143M	86.74M	48.13M	29.84M	16.47M	15.26M
Research & Development	52.04M	53.62M	44.9M	29.65M	13.26M	7.38M	4.85M	4.47M
Other Expenses	11.11M	9.01M	8.27M	1.96M	-1.88M	-2.93M	-272.42K	163.29K
Operating Expenses	263.19M	242.78M	196.17M	118.34M	59.51M	37.23M	21.32M	19.73M
Interest Expense	577K	11K	17K	1K	2.63M	4.57M	2.27M	1.65M
Selling & Marketing Expenses	123.47M	113.66M	86.61M	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	323.4M	287.76M	228.18M	134.16M	69.19M	44.54M	26.62M	24.65M
Income Tax Expense	3.32M	101K	-1.77M	-8.72M	84K	72K	8.61K	9.73K
Shares Outstanding (Basic)	27.78M	26.8M	26.05M	25.14M	18.93M	8.58M	10.65M	9.78M
Shares Outstanding (Diluted)	29.25M	26.8M	26.05M	25.14M	18.93M	8.66M	10.65M	9.78M
EPS (Basic)	0.66	-2.14	-2.58	-1.24	-0.54	0.35	-0.6	-1.26
EPS (Diluted)	0.62	-2.14	-2.58	-1.24	-0.54	-0.21	-0.6	-1.26
EBITDA	38.14M	-45.02M	-58.34M	-36.6M	-7.09M	7.69M	-3.76M	-10.4M
EBIT	22.14M	-57.35M	-68.89M	-40.01M	-7.57M	7.33M	-4.08M	-10.71M
Depreciation & Amortization	16M	12.33M	10.54M	3.41M	472K	358K	323.02K	310.82K